Established in Japan in 2003 by researchers from Kyoto University and the University of Tokyo, REPROCELL is a biotech company built around pioneering work with human embryonic and induced pluripotent stem cells. It became an early commercial supplier of iPSC-derived human cells and now supports scientists and therapy developers with stem-cell research and clinical development services.
MHLW license for production of specified processed cell products, Facility No. FA3200006
registration
European Union Manufacturer Authorization (EMA)
registration
Good Manufacturing Practice (GMP)
compliance_program
GLP/GCLP
compliance_program
ISO-compliant quality systems
compliance_program